Literature DB >> 12010175

Variable flagella expression among clonal toxin A-/B+Clostridium difficile strains with highly homogeneous flagellin genes.

H Pituch, P Obuch-Woszczatyñski, N van den Braak, A van Belkum, M Kujawa, M Luczak, F Meisel-Mikolajczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12010175     DOI： 10.1046/j.1469-0691.2002.00394.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  8 in total

Review 1.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

2.  Flagellin diversity in Clostridium botulinum groups I and II: a new strategy for strain identification.

Authors:  Catherine J Paul; Susan M Twine; Kevin J Tam; James A Mullen; John F Kelly; John W Austin; Susan M Logan
Journal:  Appl Environ Microbiol       Date:  2007-03-09       Impact factor: 4.792

Review 3.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

Review 4.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

5.  Toxigenic Clostridium difficile in retail packed chicken meat and broiler flocks in northeastern Iran.

Authors:  J Razmyar; A Jamshidi; S Khanzadi; Gh Kalidari
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

6.  Isolation of Clostridium difficile and molecular detection of binary and A/B toxins in faeces of dogs.

Authors:  M Ghavidel; H Salari Sedigh; J Razmyar
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

7.  Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection.

Authors:  Yonglin Zhou; Baichen Liu; Xiuling Chu; Jianqing Su; Lei Xu; Li Li; Xuming Deng; Dan Li; Qianghua Lv; Jianfeng Wang
Journal:  Commun Biol       Date:  2022-09-08

8.  Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.

Authors:  Chandrabali Ghose; Ioannis Eugenis; Xingmin Sun; Adrianne N Edwards; Shonna M McBride; David T Pride; Ciarán P Kelly; David D Ho
Journal:  Emerg Microbes Infect       Date:  2016-02-03       Impact factor: 7.163
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.